Best Weight Loss Injections for Women in 2026 — Ranked & Reviewed
The GLP-1 medications themselves are the same for everyone — semaglutide and tirzepatide are not gender-specific — but the programs around them differ. Women lose weight on GLP-1s at equal or slightly higher rates than men in trial data, and considerations like PCOS, perimenopause, birth-control interactions with tirzepatide, and pregnancy planning genuinely change which provider fits. This list ranks injectable GLP-1 providers with women's-health depth: menopause-certified clinicians, PCOS-aware programs, and platforms built around women's care.
Lowest verified price: $54/mo14 providers compared
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
14 weight loss injections for women compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.
- ★ Editor's Pick
mainstream telehealth GLP-1 access
From /mo$99Coverage50 statesMedicationsSemaglutideTirzepatide switching between compounded and brand-name GLP-1 through one provider
From /mo$99Coverage48 statesMedicationsSemaglutideTirzepatide- Nationwide Coverage
menopause-focused care with GLP-1 as a metabolic adjunct
From /mo$150Coverage50 statesMedicationsSemaglutideTirzepatide - Best Budget
low flat-rate compounded GLP-1 pricing at every dose
From /mo$79Coverage50 statesMedicationsSemaglutideTirzepatide budget-conscious shoppers
From /mo$99Coverage15 statesMedicationsSemaglutideTirzepatidemainstream telehealth GLP-1 access
From /mo$149Coverage50 statesMedicationsSemaglutideTirzepatideOrforglipronMenopause Society-certified care with the broadest GLP-1 formulary
From /mo$169CoverageCheck intakeMedicationsSemaglutideTirzepatideLiraglutidemultiple compounded GLP-1 formats with pharmacy quality standards
From /mo$79CoverageCheck intakeMedicationsSemaglutideTirzepatide
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick mainstream telehealth GLP-1 access | $99 | SemaglutideTirzepatide | 50 states | Visit → | |
 switching between compounded and brand-name GLP-1 through one provider | $99 | SemaglutideTirzepatide | 48 states | Visit → | |
Nationwide Coverage menopause-focused care with GLP-1 as a metabolic adjunct | $150 | SemaglutideTirzepatide | 50 states | Visit → | |
Best Budget low flat-rate compounded GLP-1 pricing at every dose | $79 | SemaglutideTirzepatide | 50 states | Visit → | |
 budget-conscious shoppers | $99 | SemaglutideTirzepatide | 15 states | Visit → | |
 mainstream telehealth GLP-1 access | $149 | SemaglutideTirzepatideOrforglipron | 50 states | Visit → | |
 Menopause Society-certified care with the broadest GLP-1 formulary | $169 | SemaglutideTirzepatideLiraglutide | Check intake | Visit → | |
 multiple compounded GLP-1 formats with pharmacy quality standards | $79 | SemaglutideTirzepatide | Check intake | Visit → |
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
Detailed Reviews
Found
Verified partnerBest for: mainstream telehealth GLP-1 access
Personalized weight care platform with a self-pay membership model plus medication costs.
Score Breakdown
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
MEDVi
Verified partnerBest for: switching between compounded and brand-name GLP-1 through one provider
MEDVi is a telehealth weight-loss platform offering compounded GLP-1 injections and tablets (semaglutide) as well as brand-name Wegovy and Zepbound through licensed US pharmacies. Medical treatment is delivered by OpenLoop Health clinicians and CareGLP Affiliated P.C.s.
Score Breakdown
Pros
- ✓Both compounded and brand-name (Wegovy, Zepbound) GLP-1 options in one platform
- ✓Oral tablet and injectable formats
- ✓Named US pharmacy partners (Triad Rx, Precision Medicine, RedRock Pharmacy, Beaker Pharmacy & Compounding)
- ✓Clinical oversight through OpenLoop Health provider network and CareGLP Affiliated P.C.s
- ✓Direct-to-home shipping with 24/7 support
Cons
- ✗Refill price for compounded GLP-1 injection ($299) steps up significantly from $179 first-month offer
- ✗Not available in Mississippi or North Dakota (telehealth regulation constraints)
- ✗Alabama and California patients can only receive injectable formats, not tablets, per state law
- ✗Kansas, Indiana, New Mexico, Oklahoma, and West Virginia require a synchronous provider visit before prescribing
- ✗No LegitScript or PCAB certification disclosed on the site
Midi Health
Verified partnerBest for: menopause-focused care with GLP-1 as a metabolic adjunct
Midi Health is a nationwide 50-state menopause and perimenopause telehealth platform. GLP-1 prescribing is offered as a clinician-discretionary metabolic-health adjunct within the menopause care framework — not as a standalone weight-loss product. Accepts commercial insurance but does NOT accept Medicare, Medicaid, or Medi-Cal.
Score Breakdown
Pros
- ✓Available in all 50 states
- ✓Accepts commercial insurance — a differentiator vs cash-pay-only GLP-1 telehealth
- ✓Menopause + metabolic-health focus suits women where GLP-1 efficacy and weight regulation overlap most
- ✓Transparent self-pay visit fees ($250 initial, $150 follow-up); GLP-1 can also be billed through commercial insurance (copay + deductible)
Cons
- ✗Does not accept Medicare, Medicaid, or Medi-Cal
- ✗GLP-1 is prescribed at clinician discretion within a menopause plan, not guaranteed at intake
- ✗Menopause-focused — not the right fit for men or younger women whose main goal is weight loss
Embody
Best for: low flat-rate compounded GLP-1 pricing at every dose
Embody offers compounded semaglutide and tirzepatide via injection plus a unique compounded oral tirzepatide gum formulation. Aggressive flat-rate pricing with all 50 states and a 24/7 clinician messaging model led by a board-certified internal medicine CMO.
Score Breakdown
Pros
- ✓Among the lowest flat rates in the compounded segment — $79/mo semaglutide and $129/mo tirzepatide injection at every dose
- ✓Unique compounded oral tirzepatide gum formulation — alternative for patients who prefer not to inject
- ✓Available in all 50 states with no insurance friction
- ✓24/7 unlimited clinician messaging and dose-adjustment support included
- ✓Medical leadership by Dr. Alan Viglione, board-certified in Internal Medicine
Cons
- ✗The $79 flat rate relies on an auto-applied promo 'locked forever' — list price in the terms is $199/mo and reviewers allege the lock isn't honored
- ✗Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
- ✗Pharmacy partners not publicly named — compounding source transparency is limited
- ✗Compounded oral tirzepatide does not have an FDA-approved counterpart, and oral GLP-1 bioavailability remains an active area of clinical debate
Mochi Health
Best for: budget-conscious shoppers
Obesity medicine telehealth provider selling compounded GLP-1s as a two-part bill: a Mochi membership at $79/mo, discounted to $39 for a first month, plus medication priced by dose from $60 for semaglutide and $90 for tirzepatide.
Score Breakdown
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
How to choose a GLP-1 provider as a woman
The medication is the same regardless of sex — but the care around it isn't. For women, the provider's depth on hormonal health, PCOS, menopause, and pregnancy planning is what separates a good fit from a generic one.
What to look for
- Hormonal-health expertise. PCOS and perimenopause both affect weight and how you respond to a GLP-1. Providers with menopause-certified clinicians or PCOS-aware programs can tailor care in ways a one-size telehealth intake can't.
- Contraception and pregnancy screening. Tirzepatide can reduce the effectiveness of oral birth control, and GLP-1s must be stopped before pregnancy. A good provider screens for this up front — not as an afterthought.
- Muscle-preserving support. Rapid loss risks lean mass. Look for providers that emphasize protein targets and resistance training alongside the medication, so you lose fat, not muscle.
Red flags to avoid
- No named pharmacy or LegitScript listing. A legitimate compounded-GLP-1 provider names its 503A/503B pharmacy partner and carries LegitScript certification. If neither is disclosed, you can't verify what you're injecting.
- Async-only, no real clinician review. A prescriber should review your intake and be reachable for dose questions. Instant approval with no way to reach a clinician is a safety gap.
- Teaser pricing that hides the real cost. A low 'first month' price that jumps at higher doses, or a membership fee stacked on top of the medication, can double the true monthly total. Confirm the ongoing, all-in price before you pay.
- Weight-loss claims for B12, MIC, or HCG shots. Only GLP-1 injections have trial evidence for weight loss. A clinic selling B12, lipotropic, or HCG shots as a weight-loss treatment is a red flag.
Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.
How we rank & what counts as “legit”
Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.
Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].
Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].
Frequently Asked Questions
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.